https://www.selleckchem.com/pr....oducts/Staurosporine
For now, only DRLs for dental and maxillofacial could be defined; because of a lack of ENT data, no DRL values for ENT practices could be derived from this survey.BACKGROUND Continuous glucose monitoring (CGM) systems help reduce hypoglycemia in patients with type 1 diabetes (T1D). It remains unclear whether T1D patients with impaired awareness of hypoglycemia (IAH) continue to develop more hypoglycemia than those with normal awareness (NA) despite CGM use. METHODS For this cross-sectional observational study, 99 T1D patients usin
Like
Comment
Share
